grant
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
Organization ROSWELL PARK CANCER INSTITUTE CORPLocation BUFFALO, UNITED STATESPosted 1 Apr 2024Deadline 31 Mar 2029
NIHUS FederalResearch GrantFY20250-11 years oldAcute Lymphoblastic LeukemiaAcute Lymphocytic LeukemiaAcute Lymphoid LeukemiaAddressAdherenceAdolescentAdolescent YouthAgeAwarenessBiological MarkersCancer RelapseCare GiversCaregiversCause of DeathCessation of lifeChildChild YouthChildhoodChildhood ALLChildhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphocytic LeukemiaChildhood Acute Lymphogenous LeukemiaChildhood Acute Lymphoid LeukemiaChildhood CancersChildren (0-21)ClinicalClinical TrialsCommunication BarriersCompanionsConfusionConfusional StateDF/HCCDana-Farber Cancer InstituteDataDeathDiseaseDisease ProgressionDisorderDrugsEducationEducational aspectsEffectiveness of InterventionsElectronicsElementsEnrollmentFamilyFamily CharacteristicsFrustrationFutureGeographic AreaGeographic LocationsGeographic RegionGeographical LocationGoalsHealth CareHealth Care CostsHealth Care ProvidersHealth Care TeamHealth CostsHealth PersonnelHomeHospital AdmissionHospitalizationHouseholdInfrastructureIngestionInstructionInterventionL1 Lymphocytic LeukemiaLymphoblastic Leukemia, Acute, L1Malignant Childhood NeoplasmMalignant Childhood TumorMalignant Pediatric NeoplasmMalignant Pediatric TumorMalignant childhood cancerMeasurementMeasuresMediatorMedical Care TeamMedicationMedicineMental ConfusionMethodologyMonitorOnly ChildParentsParticipantPatient RecruitmentsPatientsPatternPediatric ALLPediatric Acute Lymphoblastic LeukemiaPediatric Acute Lymphocytic LeukemiaPediatric Acute Lymphogenous LeukemiaPediatric Acute Lymphoid LeukemiaPharmaceutical PreparationsPhysiciansPrecursor Cell Lymphoblastic LeukemiaPrecursor Lymphoblastic LeukemiaPublic HealthRandomizedRegimenReportingReproducibilityResearchResearch DesignResearch ResourcesResistanceResourcesRiskScheduleSiteSocio-economic statusSocioeconomic StatusStandardizationStructureStudy TypeTestingTherapeutic TrialsTranslatingTranslationsTrustWorkacute lymphatic leukemiaacute lymphogenous leukemiaacute lymphomatic leukemiaagesassess effectivenessbehavior measurementbehavioral measurebehavioral measurementbio-markersbiologic markerbiomarkerbiomarker validationburn-outburnoutcancer in a childcancer in childrencancer riskcare as usualcare givingcaregivingchemotherapychild patientschild with cancerchildhood malignancyclinical practiceclinical research siteclinical significanceclinical siteclinically significantcostdesigndesigningdetermine effectivenessdrug adherencedrug compliancedrug/agenteffectiveness assessmenteffectiveness evaluationeffectiveness testingelectronicelectronic deviceenrollevaluate effectivenessexamine effectivenessexperiencefuture implementationgeographic sitehealth care personnelhealth care workerhealth providerhealth workforcehomesimplementation outcomesimplementation strategyimplementation/effectivenessimprovedinfant ALLingestinnovateinnovationinnovativeintervention designjuvenilejuvenile humankidsmarker validationmedical personnelmedication adherencemedication administrationmedication compliancemulti-site trialmultidisciplinarymultisite trialnovelparentparticipant recruitmentpediatricpediatric cancerpediatric malignancypediatric patientspharmacologicprogramsrandomisationrandomizationrandomly assignedrecruitresistantroutine carescreeningscreeningsside effectsocio-economic positionsocioeconomic positionstrategies for implementationstudy designtheoriestherapy adherencetherapy compliancetherapy designtranslationtranslational impacttreatment as usualtreatment designtreatment provideruptakeusual carevirtual educationyoungster
Description preview
Pediatric nonadherence to medication is a significant public health problem, and rigorous research repeatedly
documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and
death. Participants in our previous studies have described medication adherence as “one of the most stressful
parts” of pediatric…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click